Irene Neaman started her career in healthcare when she attended Clara Maass Memorial Hospital Nursing School and became a LPN. She then switched to Medical Technology by attending Moravian College with a laboratory internship at Hackensack Hospital. She received a BS Degree and a MT(ASCP) certification. Irene worked as a Rotating Medical Technologist at the East Orange VA Hospital followed by a position as Serology Supervisor at MetPath Inc. (now Quest Diagnostics Laboratory). Irene moved to industry as a Research Scientist at Lederle Laboratories working on new serology & immunology assays followed by a similar position at Fisher Diagnostics. She was promoted to Project Administrator where she was responsible for transferring products from R&D to the market. Irene’s next position was QA Administrator at LifeCodes, Inc. where she started the Document Control Dept. and directed the writing of documents for paternity and forensic testing. Irene joined Bayer Healthcare Diagnostics in 1991 as a Research Scientist. In 1997 she switched to Clinical Trials and worked on cancer marker studies for AFP, PSA, CA125 and HER-2/neu until 2001. From 2002-2006, Irene set-up and monitored clinical trials for Hepatitis A, B, and C and for HIV assays. Her duties have included the preparation of clinical sites for FDA inspections. In 2006, she became a Sr. CRA and Site Manager for a cardiovascular marker clinical trial. Bayer Healthcare Diagnostics was purchased by Siemens Healthcare Diagnostics Inc. in 2007. Shortly thereafter, Irene returned to clinical trials for Infectious Disease assays. From 2001-2009, Irene was Secretary of the Executive Board of the NY Chapter of the Clinical Ligand Assay Society. Irene became a member of ACRP in 2000 and a member of the NY Metro Chapter in 2004. Irene was certified as a CCRA by ACRP in 2001 and celebrated her 10th anniversary of certification in March 2011.